COL25A1
Basic information
Region (hg38): 4:108808725-109302752
Links
Phenotypes
GenCC
Source:
- fibrosis of extraocular muscles, congenital, 5 (Strong), mode of inheritance: AR
- fibrosis of extraocular muscles, congenital, 5 (Moderate), mode of inheritance: AR
- fibrosis of extraocular muscles, congenital, 5 (Moderate), mode of inheritance: AR
- ptosis, hereditary congenital, 1 (Supportive), mode of inheritance: AD
- fibrosis of extraocular muscles, congenital, 5 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Fibrosis of extraocular muscles, congenital 5 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 25500261 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (72 variants)
- not_provided (30 variants)
- COL25A1-related_disorder (14 variants)
- Fibrosis_of_extraocular_muscles,_congenital,_5 (10 variants)
- Arthrogryposis (1 variants)
- Arthrogryposis_multiplex_congenita (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COL25A1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000198721.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 21 | ||||
missense | 76 | 83 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 4 | 4 | 76 | 21 | 5 |
Highest pathogenic variant AF is 0.00000684338
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COL25A1 | protein_coding | protein_coding | ENST00000399132 | 36 | 491937 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.64e-18 | 0.894 | 124729 | 0 | 70 | 124799 | 0.000280 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.45 | 301 | 381 | 0.791 | 0.0000196 | 4101 |
Missense in Polyphen | 88 | 134.52 | 0.65416 | 1382 | ||
Synonymous | 0.0380 | 126 | 127 | 0.996 | 0.00000677 | 1346 |
Loss of Function | 2.30 | 37 | 55.5 | 0.667 | 0.00000270 | 668 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000504 | 0.000503 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000168 | 0.000167 |
Finnish | 0.000186 | 0.000186 |
European (Non-Finnish) | 0.000322 | 0.000318 |
Middle Eastern | 0.000168 | 0.000167 |
South Asian | 0.000499 | 0.000490 |
Other | 0.000333 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibits fibrillization of amyloid-beta peptide during the elongation phase. Has also been shown to assemble amyloid fibrils into protease-resistant aggregates. Binds heparin. {ECO:0000269|PubMed:15522881, ECO:0000269|PubMed:15615705, ECO:0000269|PubMed:15853808, ECO:0000269|PubMed:16300410}.;
- Disease
- DISEASE: Fibrosis of extraocular muscles, congenital, 5 (CFEOM5) [MIM:616219]: An ocular motility disorder characterized by congenital dysinnervation of various cranial nerves to ocular muscles. Clinical features are ophthalmoplegia, anchoring of the eyes in downward gaze, ptosis, and backward tilt of the head. {ECO:0000269|PubMed:25500261}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Collagen chain trimerization;Collagen biosynthesis and modifying enzymes;Collagen degradation;Collagen formation;Extracellular matrix organization;Degradation of the extracellular matrix
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.164
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.31
Haploinsufficiency Scores
- pHI
- 0.151
- hipred
- Y
- hipred_score
- 0.613
- ghis
- 0.454
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.468
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Col25a1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype;
Gene ontology
- Biological process
- extracellular matrix organization;axonogenesis involved in innervation
- Cellular component
- extracellular region;collagen trimer;extracellular space;endoplasmic reticulum lumen;plasma membrane;integral component of plasma membrane;integral component of membrane;extracellular matrix
- Molecular function
- amyloid-beta binding;extracellular matrix structural constituent;heparin binding